The Vaccine Aids Job Bounce-Back

Despite ongoing uncertainty about the on-again, off-again nature of another federal government stimulus deal, some positive news buoyed investors in the third quarter. Jobs data showed improvement and were better than expected, positive developments in Moderna's coronavirus vaccine trials occurred, and Regeneron Pharmaceuticals announced positive progress toward a treatment.

Click the Image to Read the Whole Newsletter!